Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
04:00pm, Monday, 14'th Apr 2025
The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices, home care and digital health.
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
02:05pm, Saturday, 12'th Apr 2025
With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. It's a great strategy, but it's essential to
Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last?
09:51am, Thursday, 10'th Apr 2025
Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the n
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025
04:05pm, Thursday, 03'rd Apr 2025
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial m
TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology
10:21am, Wednesday, 19'th Mar 2025
Tandem Diabetes launches Control-IQ+ technology commercially in the United States. Control-IQ+ is compatible with t:slim X2 insulin pump and Tandem Mobi System.
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
04:05pm, Tuesday, 18'th Mar 2025
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch
Reasons to Hold TNDM Stock in Your Portfolio for Now
09:46am, Tuesday, 11'th Mar 2025
A robust product innovation and several strategic developments raise investors' optimism for Tandem Diabetes.
Tandem Diabetes Q4 Earnings Review: I Don't Share The Market's Skepticism
12:44pm, Thursday, 27'th Feb 2025
Tandem Diabetes Care, Inc. released its Q4 and full-year 2024 earnings after the bell yesterday, and the market has given the stock the thumbs down. Shares are down >30% in trading today, despite a be
TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss
09:45am, Thursday, 27'th Feb 2025
Tandem Diabetes' Q4 top and bottom lines lag their respective estimate. However, the company experiences strong sales growth both in and outside the United States.
Tandem Diabetes Care, Inc. (TNDM) Q4 2024 Earnings Call Transcript
01:04am, Thursday, 27'th Feb 2025
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Susan Morrison - Executive Vice President & Chief Administrative Officer Jo
Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings
08:00pm, Wednesday, 26'th Feb 2025
While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key m
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Lags Revenue Estimates
06:30pm, Wednesday, 26'th Feb 2025
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.27 per share a year ago.
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance
04:05pm, Wednesday, 26'th Feb 2025
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year e
Tandem Diabetes Care (TNDM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Tuesday, 25'th Feb 2025
Evaluate the expected performance of Tandem Diabetes Care (TNDM) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of it
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
08:30am, Tuesday, 25'th Feb 2025
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.
